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Abstract. Metabolic pathways describe chains of enzymatic reactions.
Their modelling is a key point to understand living systems. An en-
zymatic reaction is an interaction between one or several metabolites
(substrates) and an enzyme (simple protein or enzymatic complex build
of several subunits). In our Mitochondria in Silico Project, MitoScop, we
study the metabolism of the mitochondria, an intra-cellular organelle.
Many ordinary differential equation models are available in the literature.
They well fit experimental results on flux values inside the metabolic
pathways, but many parameters are difficult to transcribe with such
models: localization of enzymes, rules about the reactions scheduler, etc
Moreover, a model of a significant part of mitochondrial metabolism
could become very complex and contain more than 50 equations.
In this context, the multi-agents systems appear as an alternative to
model the metabolic pathways. Firstly, we have looked after membrane
design. The mitochondria is a particular case because the inner mito-
chondrial space, ie matricial space, is delimited by two membranes: the
inner and the outer one. In addition to matricial enzymes, other enzymes
are located inside the membranes or in the inter-membrane space. Anal-
ysis of mitochondrial metabolism must take into account this kind of
architecture.
1 Introduction
Metabolic pathways are a set of reactions catalyzed by enzymes which takes
place inside cells. They constitute the cellular metabolism. In biology, numer-
ical simulations allow interactions between molecules to test hypotheses about
normal or pathologic behaviours. Metabolism can be viewed as a network. We
have studied mitochondria, a specific intra-cellular organelle, which has its own
enzymes and thus its own network, generally analyzed independently of the cell
metabolism.
A classical way of modeling reaction chains is to use ordinary differential
equations (ODE). With such models it is possible to describe the evolution of
the system. But many biological aspects are difficult to describe with ODE: par-
ticular situation where there are few molecules reacting (no average behaviour),
influence of the mass or the conformation of the molecules, transient association
of several molecules. However such examples correspond to biological cases like
disturbance of the network caused by lack of some molecules during a small por-
tion of time or genetic mutations which change enzyme conformation. All of this
shows that new models for simulation like these using multi-agents systems
may improve the understanding of biological processes.
One way to design a biological network is to see it as a world filled with more
or less complex entities. One entity could be a simple molecule like a metabolite
or an enzymatic complex. Each reaction is described by interactions between
entities belonging to this world. In our model, each entity is represented by
a reactive agent. This agent is situated in a 3D space and the reactions are
scheduled by time steps.
In this paper, we show what is needed to model metabolism pathways with
a multi-agents system (MAS) in the context of the mitochondrial metabolism.
We present a first approach to a 3D molecular design and the application to the
particular case of the two mitochondrial membranes: the inner and the outer
one. Each of them is composed of a phospholipids bilayer containing enzymatic
complexes. The attention is focused on a generic description of molecular inter-
actions in order to use this behaviour both for simple case as lipids and for more
complex one like respiratory chain enzymes.
2 Mitochondria: their membranes and their energetic
metabolism
Mitochondria (see Fig.1) are intra-cellular organelles which are the power plant of
the cell. They are delimited by a double membrane, composed of phospholipids,
which are naturally arranged in a bilayer to minimize their interactions with
water. The energy delivered by mitochondria comes from a complex mechanism,
involving a series of oxido-reduction reactions called ”Respiratory chain” using
oxygen we breathe in and the nutriments we ingest. They are catalyzed by
four highly structured protein complexes and electron transporters (CoenzymeQ
and CytochromeC) embedded in the inner mitochondrial membrane. Electrons
transfer is linked to an extrusion of protons outside the mitochondria, creating an
electro-chemical gradient, which will be used for ATP synthesis and other works
[6][7]. This process involves the respiratory chain and ATP synthesis, both of
them called ”Oxidative phosphorylation”. Oxidative phosphorylation has been
modelled for a long time in order to integrate all the kinetic and thermodynamic
properties of chemiosmosis theory developed by Peter Mitchell [7].
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Fig. 1. Mitochondria from http://universe-review.ca/
However some aspects, particularly the electron transports between com-
plexes I or II and complex III of the respiratory chain by a molecule called
CoQ presenting different redox states, is rather complex [8]. CoQ is certainly a
central point in electron transport in respiratory chain. This transport appears
rather difficult to model with ODE [1] due to the great variety of interactions,
of the reactions involved at different reacting sites and of the amount of the var-
ious redox CoQ species. In addition, these reactions take place inside the inner
mitochondrial membrane which is a highly heterogeneous medium (see Fig.1).
All these questions could be addressed with a multi-agents model. In fact these
problems illustrate how an MAS approach is highly suited to take care of spatial
disposition of the various enzymatic complexes, competition between different
complexes to access to some finite resources, complex interactions between sev-
eral types of molecules (membranes and enzymes) sometimes in low quantity,
environment effects (locally or not).
In the next section, we firstly describe the generic characteristics of the re-
tained MAS. Finally, we describe the specific molecular modeling (section 4).
3 A multi-agents model for metabolic pathways
Our MAS uses a 3D continuous space where the agents are situated. Situated
Agents use space as modality of their interactions. The distances between agents
are used to describe neighbouring rules. All the agents have a local perception of
their neighbourhood. A grid divides space into neighbouring units which simplify
interactions complexity giving directly neighbour positions.
The MAS is called open because of the variable number of the agent during
simulation. The continuous degradation and synthesis of molecules is a common
biological process.
The time is discretized and a scheduler is defined for each type of agents.
Actually, the inner-mitochondrial membrane is composed of enzymes and phos-
pholipids. An enzymatic reaction should not be simulated on the same time-scale
as two phospholipids interaction. One can also notice that it is possible to sim-
ulate time continuity with a discretization based on events and not on time
steps.
In general, the level used for representing the biological objects, i.e. the model
granularity, varies from atom to molecular groups (see [4] for a short review).
One can notice that an abstraction by a single point is not sufficient to take into
account a dynamic 3D structure and its spacial orientation (see Fig.2). On the
contrary, molecular modeling simulation (atom by atom) is not possible for a
whole organelle due to the large number of entities to compute.
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Fig. 2. Potentials deformations applied to a simple molecule.
A phospholipids model published by Edwards [2] uses two interacting points
per molecule. In order to design a more generic model, we have extended this pre-
vious model. Our model is suitable for modeling metabolites and enzymes alike.
Thus we have chosen to reduce each agent (molecule) to its gravity center and
its interacting points. An interacting point is a portion of molecule that could be
affected by external forces: hydrophobia, electrostatic charges, etc Fig.3 shows
the generic 3D structure (part A) and its application to a phospholipid design
(part B). Forces and torques are applied at the gravity center. Forces induce
linear acceleration whereas torques induce angular acceleration as in classical
mechanics.
Spatial localization of each interacting point is defined by a vector in the local
frame associated with the agent (molecule) using its gravity center as origin. This
design gives information about the 3D structure of the molecule and its space
orientation but also its internal dynamics.
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Fig. 3. A: abstracted 3D structure. B: application to a phospholipid.
Modeling internal dynamics could be important parameters in enzymatic
reactions. For example, an already filled active site will not be able to react with
another metabolite. A lot of enzymes interact with more than one metabolite,
in a certain order or randomly, before transforming them into new products.
The enzyme conformation could evolve after the binding of a first substrate,
revealing a second active site for a second type of substrate. Our model allows
these flexibles movements.
Even if their freedom is limited, the interacting points can be seen as agents
and thus molecules as communities of linked agents.
Each pair of interacting points defines one direction with two types of in-
teraction - attraction/repulsion. Therefore, n interacting points could induce
2n(n − 1) forces with intensity depending on the distance between agents. As
shown in Fig.4, the interactions between phospholipids can be given by 4 forces
f1, f3, f4, f5 that describe hydrophobia, another one f2 for hydrophilic and elec-
trostatic charges, and the two last ones f6, f7 for the molecular incompressibility.
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Fig. 4. Example of interaction forces for phospholipids.
As a first step, we have implemented simple functions with three parameters
(Fig.5 A): ak - maximal magnitude value of fk, rk - the radius value under which
fk magnitude is maximal - and r
′
k - the radius value over which fk is null. A sec-
ond step will be to study the impact of the choice of functions over phospholipid
structure formation that would emerge from MAS simulations. Fig.5 B shows
another function possibility.
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Fig. 5. Forces intensities are function of the distance. A: simple ramp function.
B: example of other function available.
With this approximation, the interactions between agents are reduced to a
set of forces. For a molecule i in interaction with its neighbors, the compound
force is:
−→
F i(t) = alin
∑
h
∑
j 6=i
∑
k
−→
f h,k(t)
︸ ︷︷ ︸
αlin
+ blin
−−−→
randlin(t)︸ ︷︷ ︸
βlin
− clin
−→
V i(t)︸ ︷︷ ︸
γlin
where:
⊲ αlin is the forces from the neighborhood (forces from the k interacting points
of the molecule j acting upon the h interacting points of the molecule i),
⊲ βlin is the thermal effects depending on molecule type,
⊲ γlin is the friction (
−→
Vi = molecule velocity) depending on molecule type.
Linear and rotational accelerations are thus given by Newton’s Second Law
- the fundamental law of dynamics: the acceleration of an object of constant
mass is proportional to the resultant force acting upon it (
−→
F i(t) = m
−→a ). This
compound force is used in the power series (order 2) of the position function
−→
X i(t):
−→
X i(t+ δt) =
−→
X i(t) +
d
−→
X i(t)
dt
δt+
d2
−→
X i(t)
2dt2
δt2 + o(δt2)
⇔ ∆
−→
X i(t+ δt) =
−→
V i(t)δt+
1
2
−→a i(t)δt
2 + o(δt2)
⇔ ∆
−→
X i(t+ δt) =
−→
V i(t)δt+
1
2m
−→
F i(t)δt
2 + o(δt2)
Each time step of the simulation requires for the linear movement:{
∆
−→
V i(t+ δt) ≈
1
m
−→
F i(t)δt
∆
−→
X i(t+ δt) ≈
−→
V i(t)δt+
1
2m
−→
F i(t)δt
2
where:
⊲ m is the molecule mass,
⊲
−→
X i is the vector position of the gravity center of the molecule (i.e.: the origin
of the local frame).
The forces applied by neighboring molecules induce torques. The compound
torque is:
−→
T i(t) = arot
∑
h
∑
j 6=i
∑
k
−→τ h,k(t)
︸ ︷︷ ︸
αrot
+ brot
−−−→
randrot(t)︸ ︷︷ ︸
βrot
− crot
−→
W i(t)︸ ︷︷ ︸
γrot
where:
⊲ αrot is the torques from the neighborhood (torques from the k interacting
points of the molecule j acting upon the h interacting points of the molecule
i),
⊲ βrot is the thermal effects depending on molecule type,
⊲ γrot is the rotational friction depending on molecule type.
In the same way, each time step of the simulation requires for the angular
movement: {
∆
−→
W i(t+ δt) ≈
1
I
−→
T i(t)δt
∆
−→
Θ i(t+ δt) ≈
−→
W i(t)δt+
1
2I
−→
T i(t)δt
2
where:
⊲ I is the rotational inertia linked to the molecule size,
⊲
−→
Θ i is the vector perpendicular to the rotation plan, oriented so that the
rotational movement is positive and which has a norm corresponding to the
angular variation.
This model with interaction points and gravity center seems to be a right
way to take into account the internal dynamics, the 3D structure and the space
orientation of the different biological molecules. Moreover the possibility to adapt
the agent granularity gives the possibility to design heterogeneous molecules.
4 Application to the mitochondrial membranes and
mitochondrial metabolism
In a first attempt, we used this model to design mitochondrial membranes. Two
embedded membranes appear as an important characteristic of mitochondria.
The inner membrane is the more irregular one. As can be seen in Fig.1 one
can understand that giving a mathematical definition of this form will be rather
difficult. On the other hand, using an emergent property of MAS (analogous to
natural membrane formation) can presumably be a better solution. It can take
into account the diversity of phospholipids constituting the bilayer and the fact
that the inner mitochondrial membrane is also composed of a large amount of
proteins complexes.
MAS also appear well suited to simulate the respiratory chain reactions, par-
ticularly the electron transport, which occurs inside the inner membrane and the
proton transport which occurs across it. In principle, the mitochondrial applica-
tion of our MAS model should allow the natural emergence of the complex elec-
tron transport by CoenzymeQ (CoQ) described under the name of ”Q-cycle”[8],
based on the reactions rules described for each CoQ site on complexIII.
There is another field, in which MAS would certainly have a great interest ; it
is the field of mitochondrial diseases due to deficiencies in respiratory complexes.
Mitochondrial diseases are a group of complex pathologies, which can affect
different unrelated tissues with an unexpected association of symptoms ([5],
[10]).
The disturbance in the distribution of the various CoQ species due to mu-
tations in respiratory chain complexes (giving sometimes only mild respiratory
chain deficiency) seems to be at the origin of (severe) mitochondrial diseases
[9]. Our MAS model easily describes the distribution of the various redox CoQ
species during the evolution of the reactions, for any state of the respiratory
complexes. It thus will give a strong help to describe the plausible properties
of the system and to design new experiments allowing us to better understand
these complex pathologies.
Finally reduced CoQ is an antioxidants [3]. Chemical derivatives of this
molecule are studied in order to reinforce its antioxidant properties and to treat
the oxidative stress in some mitochondrial diseases or during aging. Our MAS
model will help specifying the relevant targets of these molecules, to keep them
in their antioxidant form and thus help designing their properties.
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